We found that the PERK inhibitor GSK2606414 partially restores proteostasis, attenuates apoptosis in SIL1-deficient cells, and has beneficial effects in the woozy mouse model of MSS, attenuating PC degeneration and muscle pathology [14,15,16]. Here, SIL1 is linked to Marinesco-Sjogren syndrome.